Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity--a rebuttal.
Sallah
S
S
Isaksen
M
M
Seremetis
S
S
Payne Rojkjaer
L
L
D001779:Blood Coagulation Factors / Q000009:adverse effects*; D015942:Factor VIIa / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D007262:Infusions, Intravenous; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects*; D013927:Thrombosis / Q000139:chemically induced* / Q000453:epidemiology
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D015942:Factor VIIa